Quipt (QIPT) CAO surrenders options and 173,000 shares in $3.65 cash acquisition

Rhea-AI Filing Summary

Quipt Home Medical Corp. Chief Accounting Officer Thomas Roehrig reported disposing of all his reported equity interests in connection with the company’s cash acquisition. He returned stock options covering 50,000, 50,000 and 30,000 common shares with exercise prices of $2.45, $6.27 and $6.14 per share to the issuer. He also disposed of 173,000 common shares at $3.65 per share to the purchaser under a plan of arrangement that cashed out all outstanding common shares at $3.65 per share. Following these transactions, the filing shows no remaining shares or options held.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Roehrig Thomas

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Disposition	Stock Options (Right to Buy)	50,000	$0.00	--
Disposition	Stock Options (Right to Buy)	50,000	$0.00	--
Disposition	Stock Options (Right to Buy)	30,000	$0.00	--
Disposition	Common Shares	173,000	$3.65	$631K

Holdings After Transaction: Stock Options (Right to Buy) — 0 shares (Direct); Common Shares — 0 shares (Direct)

Footnotes (1)

1. On March 16, 2026, 1567208 B.C. LTD, a company existing under the laws of British Columbia ("B.C. Purchaser"), and REM Aggregator, LLC, a Delaware limited liability company (individually, "REM Aggregator", and collectively with B.C. Purchaser ("Purchaser" or "Purchasers") acquired all of the issued and outstanding common shares (the "Shares") of Issuer under a plan of arrangement (the "Arrangement Agreement") pursuant to the Business Corporations Act (British Columbia) (the "BCBCA"). At the Effective Time (the "Effective Time") of the Arrangement Agreement each Share, other than any Shares held by shareholders who properly exercised dissent rights under the BCBCA ("Dissenting Shareholders"), were deemed to be transferred to Purchaser in consideration for the right to receive a cash payment from the Purchaser in the amount equal to US$3.65, without interest. The Shares include restricted share units ("RSUs"), which RSUs outstanding immediately prior to the Effective Time (whether vested or unvested) were, without any further action by or on behalf of the holder of any such RSU, be deemed to be transferred by such holder to Issuer in consideration for the right to receive a cash payment from Issuer in the amount equal to US$3.65, less any amounts Issuer is required to withhold for taxes, without interest. Each RSU is the economic equivalent of one Share. Pursuant to the terms of the Arrangement Agreement, immediately following the Effective Time, each option exercisable to acquire one or more Shares from the Issuer (an "Option"), outstanding immediately prior to the Effective Time (whether vested or unvested) were deemed to be unconditionally vested and exercisable and will, without any further action by or on behalf of a holder of the Option, deemed to be surrendered and transferred by such holder to the Issuer in consideration for the right to receive a cash payment from the Issuer in an amount equal to the excess, if any, of US$3.65 over the exercise price of such option, less any amounts the Issuer is required to withhold for taxes, without interest. Any option for which the exercise price is equal to or greater than US$3.65 will be cancelled for no consideration.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roehrig Thomas

(Last) (First) (Middle)

C/O QUIPT HOME MEDICAL CORP.

1019 TOWN DRIVE

(Street)

WILDER KY 41076

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Quipt Home Medical Corp. [ QIPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/16/2026(1)		D		173,000(2)	D	$3.65	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$2.45	03/16/2026		D			50,000	(3)	(3)	Common Shares	75,000	(3)	0	D
Stock Options (Right to Buy)	$6.27	03/16/2026		D			50,000	(3)	(3)	Common Shares	75,000	(3)	0	D
Stock Options (Right to Buy)	$6.14	03/16/2026		D			30,000	(3)	(3)	Common Shares	75,000	(3)	0	D

Explanation of Responses:

1. On March 16, 2026, 1567208 B.C. LTD, a company existing under the laws of British Columbia ("B.C. Purchaser"), and REM Aggregator, LLC, a Delaware limited liability company (individually, "REM Aggregator", and collectively with B.C. Purchaser ("Purchaser" or "Purchasers") acquired all of the issued and outstanding common shares (the "Shares") of Issuer under a plan of arrangement (the "Arrangement Agreement") pursuant to the Business Corporations Act (British Columbia) (the "BCBCA"). At the Effective Time (the "Effective Time") of the Arrangement Agreement each Share, other than any Shares held by shareholders who properly exercised dissent rights under the BCBCA ("Dissenting Shareholders"), were deemed to be transferred to Purchaser in consideration for the right to receive a cash payment from the Purchaser in the amount equal to US$3.65, without interest.

2. The Shares include restricted share units ("RSUs"), which RSUs outstanding immediately prior to the Effective Time (whether vested or unvested) were, without any further action by or on behalf of the holder of any such RSU, be deemed to be transferred by such holder to Issuer in consideration for the right to receive a cash payment from Issuer in the amount equal to US$3.65, less any amounts Issuer is required to withhold for taxes, without interest. Each RSU is the economic equivalent of one Share.

3. Pursuant to the terms of the Arrangement Agreement, immediately following the Effective Time, each option exercisable to acquire one or more Shares from the Issuer (an "Option"), outstanding immediately prior to the Effective Time (whether vested or unvested) were deemed to be unconditionally vested and exercisable and will, without any further action by or on behalf of a holder of the Option, deemed to be surrendered and transferred by such holder to the Issuer in consideration for the right to receive a cash payment from the Issuer in an amount equal to the excess, if any, of US$3.65 over the exercise price of such option, less any amounts the Issuer is required to withhold for taxes, without interest. Any option for which the exercise price is equal to or greater than US$3.65 will be cancelled for no consideration.

	/s/ Thomas Roehrig	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Quipt (QIPT) Chief Accounting Officer Thomas Roehrig report in this Form 4?

Thomas Roehrig reported disposing of all his reported Quipt equity. He returned three stock option grants and 173,000 common shares as part of a cash transaction that paid $3.65 per share for all outstanding common shares.

How many Quipt (QIPT) common shares did Thomas Roehrig dispose of and at what price?

He disposed of 173,000 common shares at $3.65 per share. This occurred under a plan of arrangement where all issued and outstanding Quipt common shares were transferred to the purchaser for a cash payment of $3.65 per share.

What happened to Thomas Roehrig’s Quipt (QIPT) stock options in this transaction?

He surrendered stock options covering 50,000, 50,000 and 30,000 common shares with exercise prices of $2.45, $6.27 and $6.14. Under the arrangement, options were vested, then surrendered for cash equal to any excess over $3.65 per share.

Does Thomas Roehrig hold any Quipt (QIPT) shares or options after this Form 4?

The Form 4 shows zero common shares and zero derivative securities following the reported transactions. This indicates that, after the cash acquisition and option surrender mechanics, Roehrig no longer holds the reported Quipt equity positions.

What cash consideration did Quipt (QIPT) shareholders receive in the arrangement?

Each Quipt common share, other than those held by dissenting shareholders, was transferred to the purchaser for a cash payment of $3.65 per share, without interest, under a court-supervised plan of arrangement governed by British Columbia corporate law.

How were Quipt (QIPT) restricted share units (RSUs) treated in the transaction?

Outstanding Quipt RSUs, whether vested or unvested, were transferred to the issuer for a cash payment of $3.65 per unit, less applicable tax withholdings. Each RSU was structured as the economic equivalent of one common share in the company.

How were Quipt (QIPT) stock options treated if their exercise price exceeded $3.65?

Under the arrangement terms, any option with an exercise price equal to or greater than $3.65 per share was cancelled for no consideration. Only options with an exercise price below $3.65 were eligible for a cash payment equal to the in-the-money amount.